{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T02:02:34Z","timestamp":1789437754464,"version":"build-2803163510"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"vor","delay-in-days":81,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Imaging"],"DOI":"10.1186\/s40644-026-01079-9","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T12:56:31Z","timestamp":1782478591000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["CT-based radiomics as a non-invasive virtual biopsy for high PD-L1 expression prediction in non-small cell lung cancer"],"prefix":"10.1186","volume":"26","author":[{"given":"Michela","family":"Destito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Battaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Zaffino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Carid\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Cuc\u00e8","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Pullano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Frangipane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Francesca","family":"Spadea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Lagan\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierfrancesco","family":"Tassone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierosandro","family":"Tagliaferri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Cosentino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,26]]},"reference":[{"issue":"1","key":"1079_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nrdp.2015.9","volume":"1","author":"C Gridelli","year":"2015","unstructured":"Gridelli C, Rossi A, Carbone DP, Guarize J, Karachaliou N, Mok T, et al. Non-small-cell lung cancer. Nat Rev Dis Primers. 2015;1(1):1\u201316. https:\/\/doi.org\/10.1038\/nrdp.2015.9.","journal-title":"Nat Rev Dis Primers"},{"issue":"8","key":"1079_CR2","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/nrc3775","volume":"14","author":"Z Chen","year":"2014","unstructured":"Chen Z, Fillmore CM, Hammerman PS, Kim CF, Wong KK. Non-small-cell lung cancers: a heterogeneous set of diseases. Nat Rev Cancer. 2014;14(8):535\u201346. https:\/\/doi.org\/10.1038\/nrc3775.","journal-title":"Nat Rev Cancer"},{"issue":"9","key":"1079_CR3","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/nrclinonc.2015.90","volume":"12","author":"A Thomas","year":"2015","unstructured":"Thomas A, Liu SV, Subramaniam DS, Giaccone G. Refining the treatment of NSCLC according to histological and molecular subtypes. Nat Rev Clin Oncol. 2015;12(9):511\u201326. https:\/\/doi.org\/10.1038\/nrclinonc.2015.90.","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"1079_CR4","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1093\/annonc\/mdh011","volume":"15","author":"G Selvaggi","year":"2004","unstructured":"Selvaggi G, Novello S, Torri V, Leonardo E, De Giuli P, Borasio P, et al. Epidermal growth factor receptor overexpression correlates with a poor prognosis in completely resected non-small-cell lung cancer. Ann Oncol. 2004;15(1):28\u201332. https:\/\/doi.org\/10.1093\/annonc\/mdh011.","journal-title":"Ann Oncol"},{"issue":"9","key":"1079_CR5","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1001\/jamaoncol.2016.0639","volume":"2","author":"AG Sacher","year":"2016","unstructured":"Sacher AG, Gandhi L. Biomarkers for the clinical use of PD-1\/PD-L1 inhibitors in non\u2013small-cell lung cancer: a review. JAMA Oncol. 2016;2(9):1217\u201322. https:\/\/doi.org\/10.1001\/jamaoncol.2016.0639.","journal-title":"JAMA Oncol"},{"issue":"7","key":"1079_CR6","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/j.jtho.2016.04.014","volume":"11","author":"H Yu","year":"2016","unstructured":"Yu H, Boyle TA, Zhou C, Rimm DL, Hirsch FR. PD-L1 expression in lung cancer. J Thorac Oncol. 2016;11(7):964\u201375. https:\/\/doi.org\/10.1016\/j.jtho.2016.04.014.","journal-title":"J Thorac Oncol"},{"key":"1079_CR7","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.critrevonc.2016.03.007","volume":"101","author":"O Abdel-Rahman","year":"2016","unstructured":"Abdel-Rahman O. Correlation between PD-L1 expression and outcome of NSCLC patients treated with anti-PD-1\/PD-L1 agents: a meta-analysis. Crit Rev Oncol\/Hematol. 2016;101:75\u201385. https:\/\/doi.org\/10.1016\/j.critrevonc.2016.03.007.","journal-title":"Crit Rev Oncol\/Hematol"},{"issue":"4","key":"1079_CR8","doi-asserted-by":"publisher","first-page":"488","DOI":"10.2967\/jnumed.118.222893","volume":"61","author":"ME Mayerhoefer","year":"2020","unstructured":"Mayerhoefer ME, Materka A, Langs G, H\u00e4ggstr\u00f6m I, Szczypi\u0144ski P, Gibbs P, et al. Introduction to radiomics. J Nucl Med. 2020;61(4):488\u201395. https:\/\/doi.org\/10.2967\/jnumed.118.222893.","journal-title":"J Nucl Med"},{"issue":"9","key":"1079_CR9","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1016\/j.mri.2012.06.010","volume":"30","author":"V Kumar","year":"2012","unstructured":"Kumar V, Gu Y, Basu S, Berglund A, Eschrich SA, Schabath MB, et al. Radiomics: the process and the challenges. Magn Reson Imag. 2012;30(9):1234\u201348. https:\/\/doi.org\/10.1016\/j.mri.2012.06.010.","journal-title":"Magn Reson Imag"},{"issue":"5","key":"1079_CR10","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1111\/cas.14377","volume":"111","author":"H Shimizu","year":"2020","unstructured":"Shimizu H, Nakayama KI. Artificial intelligence in oncology. Cancer Sci. 2020;111(5):1452\u201360. https:\/\/doi.org\/10.1111\/cas.14377.","journal-title":"Cancer Sci"},{"key":"1079_CR11","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.canlet.2020.03.032","volume":"481","author":"R Cuocolo","year":"2020","unstructured":"Cuocolo R, Caruso M, Perillo T, Ugga L, Petretta M. Machine learning in oncology: a clinical appraisal. Cancer Lett. 2020;481:55\u201362. https:\/\/doi.org\/10.1016\/j.canlet.2020.03.032.","journal-title":"Cancer Lett"},{"issue":"3","key":"1079_CR12","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.radonc.2017.04.016","volume":"123","author":"van Timmeren Je","year":"2017","unstructured":"van Timmeren Je, Leijenaar RTH, van Elmpt W, Reymen B, Oberije C, Monshouwer R, et al. Survival prediction of non-small cell lung cancer patients using radiomics analyses of cone-beam CT images. Radiother Oncol. 2017;123(3):363\u201369. https:\/\/doi.org\/10.1016\/j.radonc.2017.04.016.","journal-title":"Radiother Oncol"},{"issue":"3","key":"1079_CR13","doi-asserted-by":"publisher","first-page":"285","DOI":"10.3390\/bioengineering10030285","volume":"10","author":"M Destito","year":"2023","unstructured":"Destito M, Marzullo A, Leone R, Zaffino P, Steffanoni S, Erbella F, et al. Radiomics-based machine learning model for predicting overall and progression-free survival in rare cancer: a case study for primary CNS lymphoma patients. Bioengineering. 2023;10(3):285. https:\/\/doi.org\/10.3390\/bioengineering10030285.","journal-title":"Bioengineering"},{"issue":"1","key":"1079_CR14","doi-asserted-by":"publisher","first-page":"13318","DOI":"10.1038\/s41598-025-97247-1","volume":"15","author":"L Zhang","year":"2025","unstructured":"Zhang L, Du Q, Shen M, He X, Zhang D, Huang X. Interpretable model based on MRI radiomics to predict the expression of ki-67 in breast cancer. Sci Rep. 2025;15(1):13318. https:\/\/doi.org\/10.1038\/s41598-025-97247-1.","journal-title":"Sci Rep"},{"key":"1079_CR15","doi-asserted-by":"publisher","first-page":"789014","DOI":"10.3389\/fonc.2021.789014","volume":"11","author":"J Li","year":"2021","unstructured":"Li J, Ge S, Sang S, Hu C, Deng S. Evaluation of PD-L1 expression level in patients with non-small cell lung cancer by 18F-FDG PET\/CT radiomics and clinicopathological characteristics. Front Oncol. 2021;11:789014. https:\/\/doi.org\/10.3389\/fonc.2021.789014.","journal-title":"Front Oncol"},{"issue":"1","key":"1079_CR16","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13550-023-00956-9","volume":"13","author":"X Zhao","year":"2023","unstructured":"Zhao X, Zhao Y, Zhang J, Zhang Z, Liu L, Zhao X. Predicting PD-L1 expression status in patients with non-small cell lung cancer using [18F] FDG PET\/CT radiomics. EJNMMI Res. 2023;13(1):4. https:\/\/doi.org\/10.1186\/s13550-023-00956-9.","journal-title":"EJNMMI Res"},{"issue":"10","key":"1079_CR17","doi-asserted-by":"publisher","first-page":"3401","DOI":"10.1007\/s00259-022-05783-z","volume":"49","author":"L Monaco","year":"2022","unstructured":"Monaco L, De Bernardi E, Bono F, Cortinovis D, Crivellaro C, Elisei F, et al. The \u201cdigital biopsy\u201d in non-small cell lung cancer (NSCLC): a pilot study to predict the PD-L1 status from radiomics features of [18F] FDG PET\/CT. Eur J Nucl Med Mol Imag. 2022;49(10):3401\u201311. https:\/\/doi.org\/10.1007\/s00259-022-05783-z.","journal-title":"Eur J Nucl Med Mol Imag"},{"key":"1079_CR18","doi-asserted-by":"publisher","first-page":"620246","DOI":"10.3389\/fonc.2021.620246","volume":"11","author":"Q Wen","year":"2021","unstructured":"Wen Q, Yang Z, Dai H, Feng A, Li Q. Radiomics study for predicting the expression of PD-L1 and tumor mutation burden in non-small cell lung cancer based on CT images and clinicopathological features. Front Oncol. 2021;11:620246. https:\/\/doi.org\/10.3389\/fonc.2021.620246.","journal-title":"Front Oncol"},{"issue":"3","key":"1079_CR19","doi-asserted-by":"publisher","first-page":"449","DOI":"10.3233\/XST-200642","volume":"28","author":"Z Sun","year":"2020","unstructured":"Sun Z, Hu S, Ge Y, Wang J, Duan S, Song J, et al. Radiomics study for predicting the expression of PD-L1 in non-small cell lung cancer based on CT images and clinicopathologic features. J X-Ray Sci Technol: Clin Appl Diagnosis Ther. 2020;28(3):449\u201359. https:\/\/doi.org\/10.3233\/XST-200642.","journal-title":"J X-Ray Sci Technol: Clin Appl Diagnosis Ther"},{"issue":"11","key":"1079_CR20","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1007\/s11547-021-01399-9","volume":"126","author":"S Bracci","year":"2021","unstructured":"Bracci S, Dolciami M, Trobiani C, Izzo A, Pernazza A, D\u2019Amati G, et al. Quantitative CT texture analysis in predicting PD-L1 expression in locally advanced or metastatic NSCLC patients. Radiol Med. 2021;126(11):1425\u201333. https:\/\/doi.org\/10.1007\/s11547-021-01399-9.","journal-title":"Radiol Med"},{"issue":"4","key":"1079_CR21","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1111\/1759-7714.13352","volume":"11","author":"J Yoon","year":"2020","unstructured":"Yoon J, Suh YJ, Han K, Cho H, Lee HJ, Hur J, et al. Utility of CT radiomics for prediction of PD-L1 expression in advanced lung adenocarcinomas. Thorac Cancer. 2020;11(4):993\u20131004. https:\/\/doi.org\/10.1111\/1759-7714.13352.","journal-title":"Thorac Cancer"},{"issue":"1","key":"1079_CR22","doi-asserted-by":"publisher","first-page":"11065","DOI":"10.1038\/s41598-023-38076-y","volume":"13","author":"S Yolchuyeva","year":"2023","unstructured":"Yolchuyeva S, Giacomazzi E, Tonneau M, Lamaze F, Orain M, Coulombe F, et al. Radiomics approaches to predict PD-L1 and PFS in advanced non-small cell lung patients treated with immunotherapy: a multi-institutional study. Sci Rep. 2023;13(1):11065. https:\/\/doi.org\/10.1038\/s41598-023-38076-y.","journal-title":"Sci Rep"},{"issue":"3","key":"1079_CR23","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1002\/mp.12123","volume":"44","author":"M Shafiq-Ul-Hassan","year":"2017","unstructured":"Shafiq-Ul-Hassan M, Zhang GG, Latifi K, Ullah G, Hunt DC, Balagurunathan Y, et al. Intrinsic dependencies of CT radiomic features on voxel size and number of gray levels. Med Phys. 2017;44(3):1050\u201362. https:\/\/doi.org\/10.1002\/mp.12123.","journal-title":"Med Phys"},{"issue":"9","key":"1079_CR24","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1016\/j.mri.2012.05.001","volume":"30","author":"A Fedorov","year":"2012","unstructured":"Fedorov A, Beichel R, Kalpathy-Cramer J, Finet J, Fillion-Robin JC, Pujol S, et al. 3D slicer as an image computing platform for the quantitative imaging network. Magn Reson Imag. 2012;30(9):1323\u201341. https:\/\/doi.org\/10.1016\/j.mri.2012.05.001.","journal-title":"Magn Reson Imag"},{"key":"1079_CR25","doi-asserted-by":"publisher","unstructured":"Van Griethuysen JJM, Fedorov A, Parmar C, Hosny A, Aucoin N, Narayan V, et al. Computational radiomics system to decode the radiographic phenotype. Cancer Res. 2017;77(21):e104\u201307. https:\/\/doi.org\/10.1158\/0008-5472.CAN-17-0339.","DOI":"10.1158\/0008-5472.CAN-17-0339"},{"key":"1079_CR26","unstructured":"PyRadiomics developers. PyRadiomics Documentation. 2025. Accessed: 026-02-05. Available from: https:\/\/pyradiomics.readthedocs.io\/en\/latest\/."},{"key":"1079_CR27","unstructured":"Developers S-L. StandardScaler \u2014 scikit-learn documentation. 2025. Accessed: 2026-02-05. Available from: https:\/\/scikit-learn.org\/stable\/modules\/generated\/sklearn.preprocessing.StandardScaler.html."},{"key":"1079_CR28","doi-asserted-by":"crossref","unstructured":"Chen X, Jeong JC. Enhanced recursive feature elimination. Sixth international conference on machine learning and applications (ICMLA 2007). IEEE; 2007. p. 429\u201335.","DOI":"10.1109\/ICMLA.2007.35"},{"issue":"3","key":"1079_CR29","doi-asserted-by":"publisher","first-page":"128","DOI":"10.14445\/22312803\/IJCTT-V48P126","volume":"48","author":"O F.Y","year":"2017","unstructured":"F.Y O, J.E.T A, Awodele A, J. O H, Olakanmi O, Akinjobi A, et al. Supervised machine learning algorithms: classification and comparison. Int J Comput Trends Technol (IJCTT). 2017;48(3):128\u201338. https:\/\/doi.org\/10.14445\/22312803\/IJCTT-V48P126.","journal-title":"Int J Comput Trends Technol (IJCTT)"},{"key":"1079_CR30","unstructured":"Developers S-L. RepeatedStratifiedKFold \u2014 scikit-learn documentation. 2025. Available from: Accessed: 2026-02-05. https:\/\/scikit-learn.org\/stable\/modules\/generated\/sklearn.model_selection.RepeatedStratifiedKFold.html."},{"key":"1079_CR31","doi-asserted-by":"crossref","unstructured":"Naidu G, Zuva T, Sibanda EM. A review of evaluation metrics in machine learning algorithms. Computer science on-line conference. Springer; 2023. p. 15\u201325.","DOI":"10.1007\/978-3-031-35314-7_2"},{"key":"1079_CR32","doi-asserted-by":"publisher","first-page":"110927","DOI":"10.1016\/j.engstruct.2020.110927","volume":"219","author":"S Mangalathu","year":"2020","unstructured":"Mangalathu S, Hwang SH, Jeon JS. Failure mode and effects analysis of RC members based on machine-learning-based SHapley Additive exPlanations (SHAP) approach. Eng Struct. 2020;219:110927. https:\/\/doi.org\/10.1016\/j.engstruct.2020.110927.","journal-title":"Eng Struct"},{"issue":"2","key":"1079_CR33","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s00362-012-0443-4","volume":"54","author":"S Taheri","year":"2013","unstructured":"Taheri S, Hesamian G. A generalization of the Wilcoxon signed-rank test and its applications. Stat Papers. 2013;54(2):457\u201370. https:\/\/doi.org\/10.1007\/s00362-012-0443-4.","journal-title":"Stat Papers"},{"issue":"1","key":"1079_CR34","doi-asserted-by":"publisher","first-page":"62","DOI":"10.2174\/1574886311207040289","volume":"11","author":"A Sgambato","year":"2016","unstructured":"Sgambato A, Casaluce F, Sacco P, Palazzolo G, Maione P, Rossi A, et al. Anti PD-1 and PDL-1 immunotherapy in the treatment of advanced non-small cell lung cancer (NSCLC): a review on toxicity profile and its management. CDS. 2016;11(1):62\u201368. https:\/\/doi.org\/10.2174\/1574886311207040289.","journal-title":"CDS"},{"key":"1079_CR35","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.lungcan.2017.08.005","volume":"112","author":"R Brody","year":"2017","unstructured":"Brody R, Zhang Y, Ballas M, Siddiqui MK, Gupta P, Barker C, et al. PD-L1 expression in advanced NSCLC: insights into risk stratification and treatment selection from a systematic literature review. Lung Cancer. 2017;112:200\u201315. https:\/\/doi.org\/10.1016\/j.lungcan.2017.08.005.","journal-title":"Lung Cancer"},{"issue":"11","key":"1079_CR36","doi-asserted-by":"publisher","first-page":"3129","DOI":"10.3390\/cancers12113129","volume":"12","author":"G Lamberti","year":"2020","unstructured":"Lamberti G, Sisi M, Andrini E, Palladini A, Giunchi F, Lollini PL, et al. The mechanisms of PD-L1 regulation in non-small-cell lung cancer (NSCLC): Which are the involved players? Cancers. 2020;12(11):3129. https:\/\/doi.org\/10.3390\/cancers12113129.","journal-title":"Cancers"},{"issue":"15","key":"1079_CR37","doi-asserted-by":"publisher","first-page":"19738","DOI":"10.18632\/oncotarget.7582","volume":"7","author":"F Passiglia","year":"2016","unstructured":"Passiglia F, Bronte G, Bazan V, Natoli C, Rizzo S, Galvano A, et al. PD-L1 expression as predictive biomarker in patients with NSCLC: a pooled analysis. Oncotarget. 2016;7(15):19738. https:\/\/doi.org\/10.18632\/oncotarget.7582.","journal-title":"Oncotarget"},{"issue":"5","key":"1079_CR38","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s00428-016-1910-4","volume":"468","author":"M Ilie","year":"2016","unstructured":"Ilie M, Hofman V, Dietel M, Soria JC, Hofman P. Assessment of the PD-L1 status by immunohistochemistry: challenges and perspectives for therapeutic strategies in lung cancer patients. Virchows Arch. 2016;468(5):511\u201325. https:\/\/doi.org\/10.1007\/s00428-016-1910-4.","journal-title":"Virchows Arch"},{"issue":"3","key":"1079_CR39","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.jacr.2017.12.028","volume":"15","author":"ML Giger","year":"2018","unstructured":"Giger ML. Machine learning in medical imaging. J Am Coll Radiol. 2018;15(3):512\u201320. https:\/\/doi.org\/10.1016\/j.jacr.2017.12.028.","journal-title":"J Am Coll Radiol"},{"issue":"10","key":"1079_CR40","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.3390\/sym15101834","volume":"15","author":"W Zhang","year":"2023","unstructured":"Zhang W, Guo Y, Jin Q. Radiomics and its feature selection: a review. Symmetry. 2023;15(10):1834. https:\/\/doi.org\/10.3390\/sym15101834.","journal-title":"Symmetry"},{"issue":"26","key":"1079_CR41","doi-asserted-by":"publisher","first-page":"31695","DOI":"10.1007\/s11042-024-20388-4","volume":"84","author":"A Perniciano","year":"2024","unstructured":"Perniciano A, Loddo A, Di Ruberto C, Pes B. Insights into radiomics: impact of feature selection and classification. Multimed Tools Appl. 2024;84(26):31695\u2013721. https:\/\/doi.org\/10.1007\/s11042-024-20388-4.","journal-title":"Multimed Tools Appl"},{"issue":"5","key":"1079_CR42","doi-asserted-by":"publisher","first-page":"543","DOI":"10.3390\/diagnostics15050543","volume":"15","author":"H Zhang","year":"2025","unstructured":"Zhang H, Meng X, Wang Z, Zhou X, Liu Y, Li N. Predicting PD-L1 in lung adenocarcinoma using 18F-FDG PET\/CT radiomic features. Diagnostics. 2025;15(5):543. https:\/\/doi.org\/10.3390\/diagnostics15050543.","journal-title":"Diagnostics"},{"key":"1079_CR43","doi-asserted-by":"publisher","first-page":"106915","DOI":"10.1016\/j.crad.2025.106915","volume":"86","author":"M Peng","year":"2025","unstructured":"Peng M, Wang M, Yang X, Wang Y, Xie L, An W, et al. Prediction of PD-L1 expression in NSCLC patients using PET\/CT radiomics and prognostic modelling for immunotherapy in PD-L1-positive NSCLC patients. Clin Radiol. 2025;86:106915. https:\/\/doi.org\/10.1016\/j.crad.2025.106915.","journal-title":"Clin Radiol"},{"key":"1079_CR44","doi-asserted-by":"publisher","first-page":"110742","DOI":"10.1016\/j.clinimag.2026.110742","volume":"132","author":"M Durmaz","year":"2026","unstructured":"Durmaz M, Emec M, Yirgin IK, Ilgin C, Kaval G, Bunul I, et al. CT-based radiomics for predicting PD-L1 expression status in non-small cell lung cancer using a hybrid machine learning model. Clin Imag. 2026;132:110742. https:\/\/doi.org\/10.1016\/j.clinimag.2026.110742.","journal-title":"Clin Imag"},{"issue":"1","key":"1079_CR45","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/s12885-025-15514-w","volume":"26","author":"J Li","year":"2026","unstructured":"Li J, Yang Z, Liu L, Tang F, Zheng T, Zhang C, et al. Predicting PD-L1 expression in advanced EGFR-mutant lung adenocarcinoma patients using NECT, CECT radiomics and clinical features. BMC Cancer. 2026;26(1):178. https:\/\/doi.org\/10.1186\/s12885-025-15514-w.","journal-title":"BMC Cancer"},{"issue":"19","key":"1079_CR46","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1056\/NEJMoa1606774","volume":"375","author":"M Reck","year":"2016","unstructured":"Reck M, Rodr\u00edguez-Abreu D, Robinson AG, Hui R, Cs\u0151szi T, F\u00fcl\u00f6p A, et al. Pembrolizumab versus Chemotherapy for PD-L1\u2013positive non\u2013small-Cell lung cancer. N Engl J Med. 2016;375(19):1823\u201333. https:\/\/doi.org\/10.1056\/NEJMoa1606774.","journal-title":"N Engl J Med"},{"issue":"7","key":"1079_CR47","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.3390\/cancers15071968","volume":"15","author":"F Cousin","year":"2023","unstructured":"Cousin F, Louis T, Dheur S, Aboubakar F, Ghaye B, Occhipinti M, et al. Radiomics and delta-radiomics signatures to predict response and survival in patients with non-small-cell lung cancer treated with immune checkpoint inhibitors. Cancers. 2023;15(7):1968. https:\/\/doi.org\/10.3390\/cancers15071968.","journal-title":"Cancers"},{"key":"1079_CR48","doi-asserted-by":"publisher","first-page":"1434171","DOI":"10.3389\/fimmu.2024.1434171","volume":"15","author":"J Zheng","year":"2024","unstructured":"Zheng J, Xu S, Wang G, Shi Y. Applications of CT-based radiomics for the prediction of immune checkpoint markers and immunotherapeutic outcomes in non-small cell lung cancer. Front Immunol. 2024;15:1434171. https:\/\/doi.org\/10.3389\/fimmu.2024.1434171.","journal-title":"Front Immunol"},{"key":"1079_CR49","doi-asserted-by":"publisher","first-page":"1379812","DOI":"10.3389\/fimmu.2024.1379812","volume":"15","author":"J Min","year":"2024","unstructured":"Min J, Dong F, Chen Y, Li W, Wu Y, Tan Y, et al. The NSCLC immunotherapy response predicted by tumor-infiltrating T cells via a non-invasive radiomic approach. Front Immunol. 2024;15:1379812. https:\/\/doi.org\/10.3389\/fimmu.2024.1379812.","journal-title":"Front Immunol"}],"container-title":["Cancer Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40644-026-01079-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40644-026-01079-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40644-026-01079-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T01:19:05Z","timestamp":1789435145000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40644-026-01079-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,26]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1079"],"URL":"https:\/\/doi.org\/10.1186\/s40644-026-01079-9","relation":{},"ISSN":["1470-7330"],"issn-type":[{"value":"1470-7330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,26]]},"assertion":[{"value":"1 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All data were anonymized and handled according to ethical guidelines. This observational study was approved by the Ethics Committee of the Calabria Region \u2013 Central Area Section (protocol no. 79, dated March 16, 2023). All study steps were performed in accordance with the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"127"}}